Anne-marie Verhulst-Schmitt
Marseille, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
CD8+ T-NK cell crosstalk establishes preemptive immunosurveillance to eliminate antigen-escape tumors.
Journal: Frontiers in immunology
Published: March 14, 2025
Targeting STAT3 and STAT5 in Tumor-Associated Immune Cells to Improve Immunotherapy.
Journal: Cancers
Published: October 24, 2019
Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes.
Journal: Nature communications
Published: August 02, 2016
Control of CD8 T cell proliferation and terminal differentiation by active STAT5 and CDKN2A/CDKN2B.
Journal: Immunology
Published: January 13, 2015
Molecular profiling of CD8 T cells in autochthonous melanoma identifies Maf as driver of exhaustion.
Molecular profiling of CD8 T cells in autochthonous melanoma identifies Maf as driver of exhaustion.
Journal: The EMBO journal
Published: December 12, 2014
Silence STAT3 in the procancer niche… and activate CD8+ T cells to kill premetastatic myeloid intruders.
Journal: European journal of immunology
Published: November 25, 2014
Unleashing antitumor T-cell activation without ensuing autoimmunity: the case for A20-deletion in adoptive CD8+ T-cell therapy.
Journal: Oncoimmunology
Published: August 19, 2014
The tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cells.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 16, 2014
Active STAT5 regulates T-bet and eomesodermin expression in CD8 T cells and imprints a T-bet-dependent Tc1 program with repressed IL-6/TGF-β1 signaling.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: September 06, 2013
Last Updated: 09/26/2026